A new editorial was published in Oncotarget's Volume 15 on December 24, 2024, titled "Pitfalls and perils from FDA-approved germ-line cancer predisposition tests." ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback